Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/26334
Title: Treatment choices based on multiplatform profiling platform, unlike those with sequencing alone, do not cause a cost explosion in refractory cancer patients
Authors: Russell, K. J.
JANSSENS, Jaak 
Dean, A.
Hernandez, A.
Voss, A.
Issue Date: 2017
Publisher: ELSEVIER SCIENCE INC
Source: VALUE IN HEALTH, 20(9), p. A579-A579 (Art N° PMD42)
Notes: [Russell, K. J.; Hernandez, A.; Voss, A.] Caris Life Sci, Basel, Switzerland. [Janssens, J.] Univ Hasselt, Hasselt, Belgium. [Dean, A.] St John God Hosp, Subiaco, WA, Australia.
Document URI: http://hdl.handle.net/1942/26334
ISSN: 1098-3015
e-ISSN: 1524-4733
DOI: 10.1016/j.jval.2017.08.1026
ISI #: 000413599901365
Rights: © 2017 Published by Elsevier Inc.
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
russell 2.pdf
  Restricted Access		Published version58.92 kBAdobe PDFView/Open    Request a copy
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.